Back to User profile » Dr Stefano Togni

Papers published by Dr Stefano Togni:


Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Di Pierro F, Iqtadar S, Khan A, Ullah Mumtaz S, Masud Chaudhry M, Bertuccioli A, Derosa G, Maffioli P, Togni S, Riva A, Allegrini P, Khan S

International Journal of General Medicine 2021, 14:2807-2816

Published Date: 24 June 2021

Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study

Di Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A, Allegrini P, Khan A, Khan S, Khan BA, Altaf N, Zahid M, Ujjan ID, Nigar R, Khushk MI, Phulpoto M, Lail A, Devrajani BR, Ahmed S

International Journal of General Medicine 2021, 14:2359-2366

Published Date: 8 June 2021

In vivo validation of the multicomponent powder (Vitachelox®) against the deposition of polluting ions

Giacomelli L, Togni S, Meneghin M, Eggenhöffner R, Maramaldi G

Clinical, Cosmetic and Investigational Dermatology 2018, 11:109-113

Published Date: 8 March 2018

Soothing and anti-itch effect of quercetin phytosome in human subjects: a single-blind study

Maramaldi G, Togni S, Pagin I, Giacomelli L, Cattaneo R, Eggenhöffner R, Burastero SE

Clinical, Cosmetic and Investigational Dermatology 2016, 9:55-62

Published Date: 26 February 2016

A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis

Togni S, Maramaldi G, Di Pierro F, Biondi M

Clinical, Cosmetic and Investigational Dermatology 2014, 7:321-327

Published Date: 11 November 2014

Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva®), nimesulide, and acetaminophen

Di Pierro F, Rapacioli G, Di Maio EA, Appendino G, Franceschi F, Togni S

Journal of Pain Research 2013, 6:201-205

Published Date: 8 March 2013